Navigation Links
Freiburg scientist is awarded the Paul Ehrlich and Ludwig Darmstaedter Prize
Date:3/14/2014

This news release is available in German.

This news release is available in German.

Michael Reth has won the Paul Ehrlich and Ludwig Darmstaedter Prize, awarded by the Paul Ehrlich Foundation, for his research on the immune system. For the first time since 1996, the prize goes to a scientist working in Germany. Reth is Professor for Molecular Immunology at the Institute of Biology III of the University of Freiburg and Scientific Director of the Cluster of Excellence BIOSS, Centre for Biological Signalling Studies. He is also head of the department for Molecular Immunology at the Max Planck Institute of Immunobiology and Epigenetics (MPI-IE). The prize is endowed with 100,000 and is one of the highest honours in science in Germany. By awarding the prize to Reth, the Foundation has chosen to honour a scientist who, like Nobel laureate Paul Ehrlich, decodes how immunity operates at a molecular level, in order to find new therapies for cancer and infectious diseases.

"This award is a great honour for me, because I deeply admire Paul Ehrlich's work in immunology," Reth said. "He was one of the first scientists to consider the molecular level in this field." Following Ehrlich's scientific tradition, Reth chose to focus his research on how the human body recognises foreign substances.

"Due to the success of vaccinations, which was one of the greatest achievements in medicine, immunology has been an applied science from the beginning. However, we still do not fully understand the processes that underlie immunisation," Reth remarks. That is why his research revolves around the B cell component of the immune system. When activated, these blood cells produce antibodies to fight off infection. Reth investigates the structure and organisation of the B cell antigen receptors. These molecules on the surface of B cells recognise foreign substances, so-called antigens, and trigger the activation of the immune system. Reth was able to describe the basic structure of the antigen receptor of B cells for the first time in 1989. Together with his research group, he developed a new model for the activation of this receptor and recently provided further experimental evidence for this model.

Furthermore Reth has shown that receptors on the plasma membrane have a more complex structure than previously assumed. They are not freely diffusing on the cell surface but are organized in 50 to 150 nanometre sized membrane patches also called protein islands.

Reth is the third researcher from the Max Planck Institute of Immunobiology and Epigenetics to be awarded the Paul Ehrlich and Ludwig Darmstaedter Prize. Otto Lderitz (who won the prize in 1965) and Otto Westphal (who won in 1968), both directors at the Max Planck Institute in Freiburg, also received the award for their work on the structure and effect of bacterial toxins, or so-called lipopolysaccharides.


'/>"/>

Contact: Dr. Michael Reth
michael.reth@bioss.uni-freiburg.de
49-761-510-8420
Max-Planck-Gesellschaft
Source:Eurekalert  

Related biology news :

1. Plant biology discovery furthers scientists understanding of plant growth and development
2. Tropical grassy ecosystems under threat, scientists warn
3. Scientists herd cells in new approach to tissue engineering
4. Geoscientists to meet in Fayetteville to discuss triggered seismicity, karst & energy resources
5. SURA honors Georgia Tech biologist as Distinguished Scientist
6. Scientists discover the specific types of macrophages that affect Crohns disease severity
7. Scientists to tackle burden of cattle disease on UK farms
8. Scientists highlight the importance of nutrients for coral reefs
9. Scientists learn how pathogens hack our immune systems to go undetected
10. NPL scientists blend synthetic air to measure climate change
11. Southern insect scientists meeting in Greenville, S.C.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Freiburg scientist is awarded the Paul Ehrlich and Ludwig Darmstaedter Prize
(Date:4/17/2017)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... 2016 Annual Report on Form 10-K on Thursday April 13, 2017 ... ... Investor Relations section of the Company,s website at http://www.nxt-id.com  under ... http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... Research and Markets has announced the addition of the ... ... grow at a CAGR of 30.37% during the period 2017-2021. ... prepared based on an in-depth market analysis with inputs from industry ... over the coming years. The report also includes a discussion of ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... of medical marijuana products targeting the needs of consumers who are incorporating medical ... takes place in Phoenix, Arizona. , As operators of two successful Valley dispensaries, ...
(Date:10/6/2017)... ... October 06, 2017 , ... ... the healthcare and technology sector at their fourth annual Conference where founders, investors, ... inspiring speakers and the ELEVATE pitch competition showcasing early stage digital health and ...
Breaking Biology Technology: